Evidence map›Paper›PMID 36325399›Full record

ArticleRSC medicinal chemistry2022

Tatsuya Kida, Nobuaki Takahashi, Masayuki X Mori, Jiacheng H Sun, Hideto Oota, Kosuke Nishino, Takashi Okauchi, Yuta Ochi, Daisuke Kano, Ukihide Tateishi and 4 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Tatsuya KidaLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan hisashi.doi@riken.jp.
Nobuaki TakahashiLaboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Nishikyo-ku Kyoto 615-8510 Japan mori@sbchem.kyoto-u.ac.jp.
Masayuki X MoriLaboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Nishikyo-ku Kyoto 615-8510 Japan mori@sbchem.kyoto-u.ac.jp.
Jiacheng H SunLaboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Nishikyo-ku Kyoto 615-8510 Japan mori@sbchem.kyoto-u.ac.jp.
Hideto OotaLaboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Nishikyo-ku Kyoto 615-8510 Japan mori@sbchem.kyoto-u.ac.jp.
Kosuke NishinoLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan hisashi.doi@riken.jp.
Takashi OkauchiLaboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan cuiyl@riken.jp.
Yuta OchiLaboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan cuiyl@riken.jp.
Daisuke KanoPharmaceutical department, National Cancer Center Hospital East 6-5-1 Kashiwanoha, Kashiwa-shi Chiba 277-8577 Japan.
Ukihide TateishiDepartment of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University Graduate School of Medicine 1-5-45, Yushima, Bunkyo-ku Tokyo 113-8519 Japan ttisdrnm@tmd.ac.jp.
Yasuyoshi WatanabeLaboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan.
Yilong CuiLaboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan cuiyl@riken.jp.
Yasuo MoriLaboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Nishikyo-ku Kyoto 615-8510 Japan mori@sbchem.kyoto-u.ac.jp.
Hisashi DoiLaboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research 6-7-3 Minatojima-minamimachi, Chuo-ku Kobe Hyogo 650-0047 Japan hisashi.doi@riken.jp.ORCID https://orcid.org/0000-0001-9778-5841
RIKEN Center for Biosystems Dynamics Research · JPKyoto University · JPNational Cancer Center Hospital East · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient receptor potential cation channel subfamily V member 1 (TRPV1)-targeted compounds were synthesized by modifying the structure of SB366791, a pharmaceutically representative TRPV1 antagonist. To avoid amide-iminol tautomerization, structurally supported

Identifiers

PMID36325399
PMCPMC9579943
OpenAlexW4294719405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.